This compound is an impurity reference standard for Acalabrutinib, a pharmaceutical intermediate. It is a brominated, amino-substituted imidazopyrazine derivative with a benzyl-protected pyrrolidine carboxylate structure.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2198380-46-8
1-Pyrrolidinecarboxylic acid, 2-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)-, phenylmethyl ester, (2S)-
pharmaceutical intermediate
Acalabrutinib Impurity 10
Acalabrutinib impurity reference standard
4-[5-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]-10-methyl-12-oxo-4,6,9,13-tetrazatricyclo[7.4.0.02,6]trideca-1(13),2,4,7,10-pentaen-3-yl]-N-pyridin-2-ylbenzamide
Acalabrutinib impurity reference standard
5,6-Dihydroabiraterone
Impurity standard for abiraterone synthesis
3-Fluoro-4-hydroxymethylbenzonitrile
pharmaceutical intermediate
(S)-Oxetan-2-ylmethyl 4-methylbenzenesulfonate
Pharmaceutical intermediate
Betti base hydrochloride
chiral building block for synthesis
Benzyl 2-(8-amino-1-bromo-imidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
Pharmaceutical intermediate for impurities
benzyl (2R)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
DLXYYJDQLZHBNU-CYBMUJFWSA-N
C1C[C@@H](N(C1)C(=O)OCC2=CC=CC=C2)C3=NC(=C4N3C=CN=C4N)Br
—